(Q79713040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author

Germain J.P. Fernando

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Graham R. Leggatt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Sharmal Narayan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Allison Choyce

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

406-415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

A very high level of crossreactivity is an essential feature of the T-cell receptor

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Specificity and degeneracy of T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Antigen-specific development of primary and memory T cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Progression of autoimmune diabetes driven by avidity maturation of a T-cell population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Selective induction of high avidity CTL by altering the balance of signals from APC.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

CD8 T cell responses to viral infections in sequence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Plasticity of T cell memory responses to viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

The frequency of high avidity T cells determines the hierarchy of determinant spreading

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

High avidity CD8+ T cells generated from CD28-deficient or wildtype mice exhibit a differential dependence on lipid raft integrity for activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

No one is naive: the significance of heterologous T-cell immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535688

7 January 2021

Identifiers

DOI

10.1002/EJI.200535688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17274003%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference